Breaking News Instant updates and real-time market news.

DCPH

Deciphera

$35.88

15.97 (80.21%)

09:01
08/14/19
08/14
09:01
08/14/19
09:01

Deciphera price target raised to $60 from $45 at SunTrust

SunTrust analyst Peter Lawson raised his price target on Deciphera to $60 and kept his Buy rating after its positive topline data presented for the Phase 3 trial of ripretinib in gastrointestinal stromal tumors, or GIST. The analyst says the results give him more confidence moving into the second line GIST trial and may help enrollment in the ongoing Phase 3 study. Lawson is also increasing his probability of success for the program to 90% from 80% as well as his assumed penetration to 60% from 40% in 4L+ GIST.

  • 14

    Aug

  • 15

    Aug

DCPH Deciphera
$35.88

15.97 (80.21%)

08/13/19
DBAB
08/13/19
NO CHANGE
DBAB
Buy
Deciphera price target raised to $66 after cancer data at Deutsche Bank
Deciphera Pharmaceuticals in late morning trading is up 97%, or $19.32, to $39.27.
08/14/19
ADAM
08/14/19
NO CHANGE
Target $65
ADAM
Buy
Deciphera price target raised to $65 from $50 at Canaccord
Canaccord analyst Arlinda Lee raised her price target on Deciphera to $65 from $50 following positive topline Phase3 ripretinib 4L GIST data. The analyst said the results significantly met its primary endpoint and showed notable benefit in RR and OS. He views the data as highly competitive and views its proprietary kinase switch control-based pipeline as attractive. Lee reiterated her Buy rating on Deciphera shares.
08/14/19
CANT
08/14/19
NO CHANGE
Target $55
CANT
Overweight
Deciphera price target raised to $55 from $43 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan raised his price target for Deciphera Pharmaceuticals to $55 from $43 and reiterates an Overweight rating on the shares. The analyst has increased conviction of the ripretinib programs following yesterday's topline data presented for the Phase 3 trial of ripretinib in gastrointestinal stromal tumors and "incrementally positive" update from the Phase 1 study across all lines of GIST treatment. Duncan also sees a larger total addressable market beyond his current model as a result of the recent licensing of ripretinib for development and commercialization in China to Zai Lab.
08/14/19
LEER
08/14/19
NO CHANGE
Target $29
LEER
Underperform
Deciphera price target raised to $29 from $20 at SVB Leerink
SVB Leerink analyst Andrew Berens raised his price target for Deciphera to $29 from $20 following positive top-line data from the company's Phase 3 INVICTUS trial that exceeded his expectations, in addition to favorable updates to the Phase 1 ripretinib data. The analyst reiterates an Underperform rating on the shares.

TODAY'S FREE FLY STORIES

RTRX

Retrophin

$13.58

-3.815 (-21.94%)

15:23
08/22/19
08/22
15:23
08/22/19
15:23
Recommendations
Retrophin analyst commentary  »

Retrophin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$17.69

0.73 (4.30%)

15:19
08/22/19
08/22
15:19
08/22/19
15:19
Options
Gap options imply 18.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/22/19
08/22
15:17
08/22/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSD

Clearside Biomedical

$0.78

-0.485 (-38.34%)

15:16
08/22/19
08/22
15:16
08/22/19
15:16
Recommendations
Clearside Biomedical analyst commentary  »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/22/19
08/22
15:16
08/22/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISCA

International Speedway

$45.07

(0.00%)

15:11
08/22/19
08/22
15:11
08/22/19
15:11
Hot Stocks
International Speedway announces resignation of COO Joie Chitwood »

International Speedway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$25.75

0.05 (0.19%)

15:09
08/22/19
08/22
15:09
08/22/19
15:09
Periodicals
KKR looking into sale of Epicor Software, Reuters reports »

KKR is looking into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$18.96

0.01 (0.05%)

15:04
08/22/19
08/22
15:04
08/22/19
15:04
Options
HP Inc. options imply 9.7% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

KKR

KKR

$25.74

0.04 (0.16%)

15:00
08/22/19
08/22
15:00
08/22/19
15:00
Periodicals
Breaking Periodicals news story on KKR »

KKR looking into sale of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$147.63

0.23 (0.16%)

14:49
08/22/19
08/22
14:49
08/22/19
14:49
Options
Salesforce options imply 8.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

MYGN

Myriad Genetics

$23.88

-1.24 (-4.94%)

14:44
08/22/19
08/22
14:44
08/22/19
14:44
Recommendations
Myriad Genetics analyst commentary at Piper Jaffray »

LCD's incrementally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 13

    Nov

PINC

Premier

$37.88

0.1 (0.26%)

14:36
08/22/19
08/22
14:36
08/22/19
14:36
Recommendations
Premier analyst commentary at Piper Jaffray »

Piper says Premier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

CAH

Cardinal Health

$43.87

0.31 (0.71%)

14:35
08/22/19
08/22
14:35
08/22/19
14:35
Options
Cardinal Health put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

MO

Altria Group

$46.24

-0.01 (-0.02%)

14:30
08/22/19
08/22
14:30
08/22/19
14:30
Hot Stocks
Altria Group raises quarterly dividend to 84c per share from 80c »

Altria Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$204.11

0.27 (0.13%)

, ALXN

Alexion

$125.28

10.41 (9.06%)

14:29
08/22/19
08/22
14:29
08/22/19
14:29
On The Fly
Analyst says rumored Amgen bid for Alexion 'could make a ton of sense' »

After Spanish publication…

AMGN

Amgen

$204.11

0.27 (0.13%)

ALXN

Alexion

$125.28

10.41 (9.06%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 02

    Sep

  • 06

    Sep

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 02

    Oct

  • 19

    Oct

  • 04

    Nov

FL

Foot Locker

$41.82

2.06 (5.18%)

, HIBB

Hibbett Sports

$17.04

0.88 (5.45%)

14:29
08/22/19
08/22
14:29
08/22/19
14:29
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FL

Foot Locker

$41.82

2.06 (5.18%)

HIBB

Hibbett Sports

$17.04

0.88 (5.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

CRM

Salesforce

$147.66

0.26 (0.18%)

, INTU

Intuit

$276.18

-0.16 (-0.06%)

14:28
08/22/19
08/22
14:28
08/22/19
14:28
Earnings
Notable companies reporting after market close »

Notable companies…

CRM

Salesforce

$147.66

0.26 (0.18%)

INTU

Intuit

$276.18

-0.16 (-0.06%)

VMW

VMware

$147.20

-0.84 (-0.57%)

ROST

Ross Stores

$107.05

1.37 (1.30%)

HPQ

HP Inc.

$18.95

(0.00%)

GPS

Gap

$17.58

0.62 (3.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 10

    Sep

  • 25

    Sep

  • 10

    Oct

  • 27

    Oct

  • 12

    Dec

  • 16

    Dec

SPLK

Splunk

$117.83

-10.68 (-8.31%)

14:24
08/22/19
08/22
14:24
08/22/19
14:24
Recommendations
Splunk analyst commentary at BMO Capital »

BMO Capital remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 15

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/22/19
08/22
14:17
08/22/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/22/19
08/22
14:16
08/22/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$8.41

-0.28 (-3.22%)

14:15
08/22/19
08/22
14:15
08/22/19
14:15
Options
Whiting Petroleum put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 08

    Oct

  • 09

    Oct

14:15
08/22/19
08/22
14:15
08/22/19
14:15
General news
Breaking General news story  »

Minneapolis Federal…

NWS

News Corp

$14.48

0.02 (0.14%)

, NWSA

News Corp.

$14.17

0.07 (0.50%)

14:12
08/22/19
08/22
14:12
08/22/19
14:12
Periodicals
News Corp prepares news app to address concerns with Google, Facebook, WSJ says »

News Corp (NWSA) is…

NWS

News Corp

$14.48

0.02 (0.14%)

NWSA

News Corp.

$14.17

0.07 (0.50%)

GOOG

Alphabet

$1,191.47

0.68 (0.06%)

GOOGL

Alphabet Class A

$1,192.10

1.84 (0.15%)

FB

Facebook

$181.72

-1.84 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 23

    Sep

  • 24

    Sep

  • 27

    Oct

AMZN

Amazon.com

$1,815.98

-7.21 (-0.40%)

14:00
08/22/19
08/22
14:00
08/22/19
14:00
Periodicals
Amazon acquires 49% interest in India's Future Coupons, TechCrunch reports »

Amazon has acquired a 49%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

BTHE

Boston Therapeutics

$0.00

(0.00%)

13:56
08/22/19
08/22
13:56
08/22/19
13:56
Hot Stocks
Boston Therapeutics BTI320 Phase 2 study achieves full enrollment »

Boston Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.